An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis

Background: Sepsis is a syndrome characterised by a systemic inflammatory response to infection that leads to rapid acute organ failure and potentially rapid decline to death. Intravenous immunoglobulin (IVIG), a blood product derived from human donor blood, has been proposed as an adjuvant therapy...

Full description

Bibliographic Details
Main Authors: MO Soares, NJ Welton, DA Harrison, P Peura, MS Hari, SE Harvey, JJ Madan, AE Ades, SJ Palmer, KM Rowan
Format: Article
Language:English
Published: NIHR Journals Library 2012-02-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/hta16070